Medicare will pay dialysis facilities more in 2027, and smaller facilities will see the most structural change. On 28 October 2026 the Centers for Medicare & Medicaid Services issued the calendar year 2027 End-Stage Renal Disease Prospective Payment System final rule, lifting the bundled base rate to $297.52 per treatment, up $15.81 from $281.71 in 2026. CMS projects total payments to roughly 7,600 end-stage renal disease facilities at about $7.0 billion, an increase of approximately 2.7% for both freestanding and hospital-based facilities. The rule also widens the low-volume adjustment, raises home-dialysis training payments, completes the folding of phosphate binders into the bundled rate, and reshapes the quality programme from payment year 2029.
What the Rule Changes
The base rate increase is built from several components. The rate reflects a 1.9% market basket update and budget neutrality adjustments, plus a $12.85 addition completing the incorporation of phosphate binders into the bundled payment, a process begun on 1 January 2025. The acute kidney injury dialysis rate is set equal to the new base rate, also $297.52, and from 2027 facilities are responsible for providing medically necessary phosphate binders to acute kidney injury patients under their direct care. The June proposal had put the base rate at $299.55 with total payments up about 1.1%.
Small Facilities and Home Dialysis Gain Most
The most consequential change for smaller operators is the low-volume payment adjustment. CMS is raising its threshold from 4,000 to 8,000 treatments a year and expanding it from two tiers to six, so that facilities furnishing between 4,000 and 8,000 treatments annually, which generally incur higher costs than higher-volume units, now qualify for an adjustment. The largest adjustment goes to facilities with fewer than 3,000 median treatments over the past three cost reporting years, and the smallest to those with 7,000 to 7,999. Facilities may attest that they meet the requirements up to 31 December 2026 to receive the adjustment for 2027. Separately, the home and self-dialysis training add-on rises from $95.60 to $138.00 and, for the first time, becomes payable during the onset period, the first four months of dialysis, with an onset adjustment factor of 1.311 to account for payment overlap. Paediatric payment adjustments are also updated to reflect the end of the temporary paediatric adjustment in 2027, using more recent cost data and extending the low-volume adjustment to qualifying paediatric treatments.
What Changes in the Quality Programme
The quality changes arrive later, from payment year 2029, but facilities should plan for them now because they change what gets measured. CMS is replacing the Hypercalcemia reporting measure with a Hyperphosphatemia clinical measure to better assess patient outcomes. Two reporting measures are removed: Medication Reconciliation, where CMS cites consistently high performance and a documentation burden that outweighs the benefit, and COVID-19 vaccination coverage among healthcare personnel, which no longer aligns with current clinical guidance since the end of the public health emergency. The Reporting Measure Domain is removed, with weights redistributed, and the bloodstream infection measure moves to a 2023 baseline with revised risk adjustment.
What This Means for Dialysis Facilities
For dialysis providers, the immediate task is arithmetic: re-run 2027 revenue forecasts on the $297.52 base rate, check low-volume eligibility before the 31 December attestation deadline, and price the home-dialysis training opportunity into staffing plans, since training is now paid from the first months of treatment rather than only afterwards. Hospital-based units should check the same numbers against their own case mix and wage index. The quality changes deserve a longer runway: the new clinical measure rewards phosphorus management spanning dietetics, prescribing and dialysis prescription. For referring clinics, dialysis economics shape access: a viable small unit and a funded home-training programme keep treatment close to patients who need it three times a week.
Analysis: A Raise That Rewards Scale Differently
Read as a whole, the rule is less a simple pay rise than a rebalancing. The base rate rise is modest and partly absorbed by the budget-neutral adjustments around it, while the real redistribution runs through the low-volume tiers and the home-training payment: money steered toward smaller units whose costs do not scale, and toward home dialysis, which CMS has long said it wants to grow. That is a coherent strategy, but it puts the burden on operators to claim it: the low-volume adjustment requires attestation, the training payment requires a training programme, and the quality gains require clinical reorganisation before 2029. Facilities that treat the final rule as a rate to plug into a spreadsheet will capture the 2.7%. Facilities that act on its incentives may capture considerably more. The risk runs the other way too: units that miss the attestation deadline or leave home training unbuilt will watch the increase flow to competitors that did not.
Dialysis facilities and nephrology practices updating scheduling, intake and patient communication for 2027 can explore MedClinicX's AI patient portal, see how after-hours calls are handled on our AI medical receptionist page, or explore the demos and request a quote for their own practice.
Sources and References
- Centers for Medicare & Medicaid Services, Calendar Year (CY) 2027 End-Stage Renal Disease (ESRD) Prospective Payment System Final Rule, CMS-1846-F, issued 28 October 2026: https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2027-end-stage-renal-disease-esrd-prospective-payment-system-final-rule-cms-1846-f
- Healthcare Finance News, CMS more than doubles dialysis payment increase for 2027, 29 October 2026: https://www.healthcarefinancenews.com/news/cms-more-doubles-dialysis-payment-increase-2027
- Bloomberg Law, HHS Raises Dialysis Reimbursements, Updates Quality Standards, 28 October 2026: https://news.bloomberglaw.com/health-law-and-business/hhs-raises-dialysis-reimbursements-updates-quality-standards
Reporting based on the sources above, accessed 30 October 2026. The CMS fact sheet and the Healthcare Finance News report were read directly in full and cross-checked against each other. The Bloomberg Law report was used only to confirm the event, rate and date, as its full text is paywalled. MedClinicX did not conduct original reporting or interviews for this article. This article is for information only and is not financial or reimbursement advice. Corrections: contact us via https://medclinicx.com/contact